We help international patients explore hospitals in China by city and specialty, understand likely costs, and prepare records and appointments before they travel.
We help you understand your options before you commit to treatment travel.
Tell us about your condition, timing, and any hospitals or doctors you already have in mind.
We help you compare suitable hospitals, likely costs, and the practical differences that matter most.
When you are ready, we help you prepare records, appointments, and the next steps before travel.
Start with a lighter review or choose hands-on support if you want help preparing before travel.
For patients still researching — get a clear shortlist of hospitals, cost expectations, and a practical plan before you commit.
For patients ready to move — we handle hospital contact, appointments, pre-arrival planning, and airport pickup.
Patients come to us for clearer guidance, honest expectations, and practical help before they travel.
We help you understand your options, while treatment decisions remain with the hospital and doctors.
We focus on the details patients actually need: hospital fit, likely costs, records, timing, and what to prepare.
You know what to send, how we respond, and what happens after you start a paid service.
Practical resources for foreigners, expats, students, and international patients trying to understand healthcare in China.
Learn how public hospitals, private hospitals, emergency care, registration, payment, and insurance usually work.
Keep useful Chinese phrases ready for registration, symptoms, allergies, pharmacy, records, insurance, and emergencies.
Review what to prepare before a consultation, from medical records and imaging to costs, travel, and follow-up questions.
Stay updated on global medical tourism developments and China healthcare breakthroughs.
A hantavirus outbreak on the cruise ship MV Hondius has killed 3 people and infected at least 8 passengers since April 2026. The A
Read more →The FDA has issued a 'safe to proceed' letter for daraxonrasib, allowing Revolution Medicines to offer its investigational KRAS G1
Read more →On May 1, 2026, the FDA approved vepdegestrant (VEPPANU), the first-ever PROTAC protein degrader for ER+/HER2-/ESR1-mutated metast
Read more →